RECURSION PHARMACEUTICALS IN shareholders Q3 2023

RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 190 filers reported holding RECURSION PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.9%.

RECURSION PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Plancorp, LLC 10,700$81,8550.00%
Ameritas Investment Partners, Inc. 13,560$103,7340.00%
MARTINGALE ASSET MANAGEMENT L P 25,113$192,1150.00%
Independent Advisor Alliance 12,500$95,6250.00%
IEQ CAPITAL, LLC 26,880$205,6320.00%
PRINCIPAL FINANCIAL GROUP INC 645,475$4,937,8830.00%
Ensign Peak Advisors, Inc 214,970$1,644,5210.00%
Pentwater Capital Management LP 100,000$765,0000.00%
Pentwater Capital Management LP 100,000$765,0000.00%
MetLife Investment Management, LLC 72,161$552,0320.00%
MILLENNIUM MANAGEMENT LLC 658,355$5,036,4160.00%
GUGGENHEIM CAPITAL LLC 43,931$336,0720.00%
Nuveen Asset Management, LLC 987,339$7,553,1430.00%
VANGUARD GROUP INC 15,506,834$118,627,2800.00%
GEODE CAPITAL MANAGEMENT, LLC 3,138,690$24,014,0640.00%
LAZARD ASSET MANAGEMENT LLC 335,024$2,5620.00%
METROPOLITAN LIFE INSURANCE CO/NY 7,922$60,6030.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1,157,966$8,858,4400.00%
BARCLAYS PLC 557,771$4,2660.00%
AMERICAN INTERNATIONAL GROUP, INC. 68,112$521,0570.00%
External links

This page lists RECURSION PHARMACEUTICALS IN's shareholders in Q3 2023. To view RECURSION PHARMACEUTICALS IN's shareholder history, click here.